Found: 8
Select item for more details and to access through your institution.
Baseline Splenic Volume as a Prognostic Biomarker of FOLFIRI Efficacy and a Surrogate Marker of MDSC Accumulation in Metastatic Colorectal Carcinoma.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1429, doi. 10.3390/cancers12061429
- By:
- Publication type:
- Article
Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous infusion in patients with advanced colorectal carcinoma.
- Published in:
- Cancer (0008543X), 1997, v. 79, n. 6, p. 1100, doi. 10.1002/(SICI)1097-0142(19970315)79:6<1100::AID-CNCR7>3.0.CO;2-J
- By:
- Publication type:
- Article
Cholangitis Due to Pancreaticobiliary Fistula and Intraductal Papillary Mucinous Neoplasm: Thick Mucus Alters the Effectiveness of Biliary Drainage.
- Published in:
- JOP Journal of the Pancreas, 2018, v. 19, n. 4, p. 219
- By:
- Publication type:
- Article
Prognostic value of circulating tumour DNA in metastatic pancreatic cancer patients: post-hoc analyses of two clinical trials.
- Published in:
- British Journal of Cancer, 2022, v. 126, n. 3, p. 440, doi. 10.1038/s41416-021-01624-2
- By:
- Publication type:
- Article
Prognostic value of circulating tumour DNA in metastatic pancreatic cancer patients: post-hoc analyses of two clinical trials.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Association of COVID-19 Lockdown With the Tumor Burden in Patients With Newly Diagnosed Metastatic Colorectal Cancer.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 9, p. e2124483, doi. 10.1001/jamanetworkopen.2021.24483
- By:
- Publication type:
- Article
Clinico-biological factors predicting the benefit of the LV5FU2 maintenance strategy as a first-line therapy in patients with metastatic pancreatic cancer.
- Published in:
- Oncologist, 2024, v. 29, n. 9, p. e1149, doi. 10.1093/oncolo/oyae079
- By:
- Publication type:
- Article
Predicting Chemotherapy Toxicity and Death in Older Adults with Colon Cancer: Results of MOST Study.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. e85, doi. 10.1634/theoncologist.2019-0241
- By:
- Publication type:
- Article